RE: KenChowder (since Chowder has blocked my linked reply): Why would any thinking person want to mix Remdeathisvir with Leronlimab for a trial? The toxicity and failure of Remdeathisvir has been established. The fact that it was approved just exposes the "problems" with the FDA, and I'm being kind. Leronlimab will do just fine by itself in trials, but thanks for the suggestion.